Articole cu mandate pentru acces public - Siddhartha Yadav, MD, FACPAflați mai multe
Respinse: 1
Impact of bariatric surgery on outcomes of patients with sickle cell disease: a nationwide inpatient sample analysis, 2004–2014
P Sharma, TR McCarty, S Yadav, JN Ngu, B Njei
Obesity surgery 29 (6), 1789-1796, 2019
Mandate: US National Institutes of Health
Autori responsabili: P Sharma
Disponibile undeva: 42
A population-based study of genes previously implicated in breast cancer
C Hu, SN Hart, R Gnanaolivu, H Huang, KY Lee, J Na, C Gao, J Lilyquist, ...
New England Journal of Medicine 384 (5), 440-451, 2021
Mandate: US National Institutes of Health, State of Califonia, Susan G. Komen
Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century
S Yadav, D Karam, I Bin Riaz, H Xie, U Durani, N Duma, KV Giridhar, ...
Cancer 126 (1), 26-36, 2020
Mandate: US National Institutes of Health
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
DR Barnes, MA Rookus, L McGuffog, G Leslie, TM Mooij, J Dennis, ...
Genetics in Medicine 22 (10), 1653-1666, 2020
Mandate: US National Institutes of Health, Cancer Research UK, Wellcome Trust
Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
S Yadav, NJ Boddicker, J Na, EC Polley, C Hu, SN Hart, RD Gnanaolivu, ...
Journal of Clinical Oncology 41 (9), 1703-1713, 2023
Mandate: US National Institutes of Health, State of Califonia, Susan G. Komen
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer
M Kohli, W Tan, T Zheng, A Wang, C Montesinos, C Wong, P Du, S Jia, ...
EBioMedicine 54, 2020
Mandate: US National Institutes of Health, National Health and Medical Research …
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer
S Yadav, C Hu, SN Hart, N Boddicker, EC Polley, J Na, R Gnanaolivu, ...
Journal of Clinical Oncology 38 (13), 1409-1418, 2020
Mandate: US National Institutes of Health
The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort
C Hu, EC Polley, S Yadav, J Lilyquist, H Shimelis, J Na, SN Hart, ...
JNCI: Journal of the National Cancer Institute 112 (12), 1231-1241, 2020
Mandate: US National Institutes of Health
Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline
I Bedrosian, MR Somerfield, MI Achatz, JC Boughey, G Curigliano, ...
Journal of Clinical Oncology 42 (5), 584-604, 2024
Mandate: US National Institutes of Health
Contribution of germline predisposition gene mutations to breast cancer risk in African American women
JR Palmer, EC Polley, C Hu, EM John, C Haiman, SN Hart, M Gaudet, ...
JNCI: Journal of the National Cancer Institute 112 (12), 1213-1221, 2020
Mandate: US National Institutes of Health, Susan G. Komen
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
N Cosgrove, D Varešlija, S Keelan, A Elangovan, JM Atkinson, ...
Nature Communications 13 (1), 1-16, 2022
Mandate: US National Institutes of Health, Science Foundation Ireland, Breast Cancer …
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis
KP Lowry, HA Geuzinge, NK Stout, O Alagoz, J Hampton, K Kerlikowske, ...
JAMA oncology 8 (4), 587-596, 2022
Mandate: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer —Association With Patient and Disease Characteristics and Effect on …
PA Fasching, S Yadav, C Hu, M Wunderle, L Häberle, SN Hart, M Rübner, ...
Journal of Clinical Oncology 39 (15), 1619-1630, 2021
Mandate: US National Institutes of Health
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness
VL Patel, EL Busch, TM Friebel, A Cronin, G Leslie, L McGuffog, J Adlard, ...
Cancer research 80 (3), 624-638, 2020
Mandate: US Department of Defense, US National Institutes of Health, National Health …
Safety of influenza vaccine in patients with cancer receiving pembrolizumab
JJ Failing, TP Ho, S Yadav, N Majithia, IB Riaz, JY Shin, EL Schenk, H Xie
JCO oncology practice 16 (7), e573-e580, 2020
Mandate: US National Institutes of Health
Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African Ancestry
M Matejcic, Y Patel, J Lilyquist, C Hu, KY Lee, RD Gnanaolivu, SN Hart, ...
JCO Precision Oncology 4, 32-43, 2020
Mandate: US National Institutes of Health, State of Califonia
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
J Coignard, M Lush, J Beesley, TA O’Mara, J Dennis, JP Tyrer, DR Barnes, ...
Nature Communications 12 (1), 1-22, 2021
Mandate: US Department of Defense, US National Institutes of Health, National Health …
Germline pathogenic variants in cancer predisposition genes among women with invasive lobular carcinoma of the breast
S Yadav, C Hu, KL Nathanson, JN Weitzel, DE Goldgar, P Kraft, ...
Journal of Clinical Oncology 39 (35), 3918-3926, 2021
Mandate: US National Institutes of Health, State of Califonia, Susan G. Komen
Mutation prevalence tables for hereditary cancer derived from multigene panel testing
SN Hart, EC Polley, A Yussuf, S Yadav, DE Goldgar, C Hu, H LaDuca, ...
Human mutation 41 (8), e1-e6, 2020
Mandate: US National Institutes of Health
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study
M Lambertini, E Blondeaux, E Agostinetto, AS Hamy, HJ Kim, A Di Meglio, ...
JAMA 331 (1), 49-59, 2024
Mandate: US National Institutes of Health, National Health and Medical Research …
Informațiile despre publicații și finanțare sunt alese automat de un program informatic